Clean Science And Technology Archives

MRF Q1 Results: Net profit rises 12-fold YoY to Rs 166 crore

MRF Limited reported a 1,130% YoY jump in consolidated net profit to Rs 165.58 crore for the quarter ended June (Q1 FY22). However, net profit has declined by 50.15% when compared to the previous quarter. Its revenue from operations rose 70% YoY to Rs 4,184 crore during the same period. EBITDA grew 49.2% YoY to Rs 2,460.7 crore in Q1. The tyre manufacturer’s total expenses increased by 63.5% YoY to Rs 4,054.24 crore during the April-June quarter of FY22.

Read more here.

Amara Raja Batteries to acquire 11.36% stake in Log 9 for Rs 37 crore

Amara Raja Batteries Ltd (ARBL) will invest ~Rs 37 crore for acquiring an 11.36% stake in Log 9 Materials Scientific Pvt Ltd, a Bengaluru-based battery-tech and deep-tech startup. ARBL is expected to be the primary partner for scaling up the manufacturing operations of Log 9’s battery and fuel cell technologies. The investment is part of ARBL’s ‘Energy & Mobility’ strategy, which focuses on entering into green technologies and solutions.

Read more here.

AstraZeneca Pharma Q1 Results: Net profit falls 45% YoY to Rs 10.24 crore

AstraZeneca Pharma India Ltd reported a 45.62% YoY decline in net profit to Rs 10.24 crore for the quarter ended June (Q1 FY22). Net profit has declined by 62.45% when compared to the previous quarter. Its revenue from operations fell 9.3% YoY to Rs 175.4 crore during the same period. The pharma company’s board has declared an interim dividend of Rs 2 per share.

Read more here.

Govt looks to cut import duties on electric cars to as low as 40%: Report

According to a report from Reuters, India is considering slashing import duties on electric cars to as low as 40%. The government plans to cut the tax rate from 60% to 40% for electric cars under $40,000 (~Rs 29.69 lakh). For EVs valued at more than $40,000, the Centre is looking at cutting the rate from 100% to 60%. This comes days after Tesla Inc appealed for a cut in India’s import duties. The EV giant argued that lowering import duties on EVs to 40% would make them more affordable and boost sales.

Read more here.

Subex Q1 Results: Net profit falls 11% YoY to Rs 13.48 crore

Subex Ltd reported an 11.08% YoY decline in consolidated net profit to Rs 13.48 crore for the quarter ended June (Q1 FY22). Net profit has declined by 13.6% when compared to the previous quarter. Its total income fell 2.62%% YoY (or 10.8% QoQ) to Rs 87.31 crore during the same period. Subex is an enterprise software company that provides digital trust products to communication service providers.

Equity mutual fund inflows surge more than three-fold in July

Investment into equity mutual funds surged more than three-fold in July amidst optimism about the economy, as restrictions eased after the second wave of Covid-19. Net inflows into equity and equity-linked schemes jumped ~277% over the preceding month to Rs 22,583.5 crore in July 2021. This is the fifth-straight month of inflows into the category and is the highest since April 2018. The data was released by the Association of Mutual Funds in India (AMFI).

Read more here.

Balrampur Chini Mills Q1: Net profit falls 44% YoY to Rs 77 crore

Balrampur Chini Mills Ltd reported a 44.7% YoY decline in consolidated net profit to Rs 77.92 crore for the quarter ended June (Q1 FY22). Net profit has declined by 67.34% when compared to the previous quarter. Its revenue from operations fell 20.2% YoY to Rs 1,140.44 crore during the same period. The company’s board has approved a proposal to buy back up to 52.5 lakh equity shares at a maximum price of Rs 410 per share. The Board of Directors has also approved a further expansion of ethanol production from 840-kilo litre per day (KLPD) to 1,050 KLPD.

Read more here.

Shree Cements Q1 Results: Net profit rises 91% YoY to Rs 630 crore

Shree Cements Ltd reported a 91.11% YoY increase in consolidated net profit to Rs 629.9 crore for the quarter ended June (Q1 FY22). Net profit has declined by 21.1% when compared to the previous quarter. Its total income rose 44.5% YoY (but declined by 13.3% QoQ) to Rs 3,775.9 crore during the same period.

Clean Science and Tech Q1 Results: Net profit rises 30% YoY to Rs 54 crore

Clean Science and Technology Ltd reported a 30.3% YoY increase in consolidated net profit to Rs 54.6 crore for the quarter ended June (Q1 FY22). Net profit has increased by 2.7% when compared to the previous quarter. Its revenue from operations rose 29.62% YoY (or 9.2% QoQ) to Rs 146.4 crore during the same period. Clean Science and Tech is a specialty chemical manufacturer based in Pune, Maharashtra.

Read more here.

CarTrade Tech IPO subscribed 41% on first day of bidding

The Rs 2,998.5 crore initial public offering (IPO) of CarTrade Tech was subscribed 41% on the first day of bidding. Retail investors have subscribed 0.8% against their reserved portion. Non Institutional investors (NIIs) and Qualified Institutional Buyers (QIBs) have subscribed 3% and 1%, respectively, against their reserved portions. To learn more about the IPO, click here.

Meanwhile, the Rs 5,000 crore initial public offering (IPO) of Nuvoco Vistas Corp was subscribed 16% on the first day of bidding. Retail investors have subscribed 31% against their reserved portion. Non Institutional investors (NIIs) have subscribed 1% against their reserved portion.

Indian Hotels Q1 Results: Net loss at Rs 277 crore

The Indian Hotels Company Ltd (IHCL) reported a consolidated net loss of Rs 277 crore for the quarter ended June (Q1 FY22). It had posted a net loss of Rs 279.9 crore in the corresponding quarter last year (Q1 FY21). Its revenue from operations jumped 139% YoY to Rs 344.55 crore in Q1 FY22. IHCL is a hospitality company that manages a wide portfolio of hotels, resorts, spas, etc. It is a subsidiary of the Tata Group.

The story of this chemical company started on November 7, 2003 in Pune. Back then, it was called ‘Sri Distikemi Private Limited’, a very traditional name compared to what we know it today as. The name was changed to ‘Clean Science and Technology Private Limited’ in 2006 after its shareholders decide to adopt a more ‘sustainable’ and ‘clean’ method to manufacture chemicals.

Clean Science and Technology has come up with an IPO, starting on July 7, 2021. In this piece, we analyze the company’s business model and its financial health to determine if it has potential in the markets.

Business Model

Clean Science and Technology is a speciality chemical manufacturer that produces chemicals used for ‘special’ purposes. These chemicals can be used in manufacturing a sunscreen lotion, medicine, or even a bag of chips. Based on segmental revenue, the company manufactures the following chemicals:

Performance Chemicals (~69% of total revenue) – Mequinol (MEHQ), Beta-Hydroxy Acid (BHA).

Pharmaceutical Intermediates (~16% of total revenue) – Guaiacol, DCC

FMCG Chemicals (~12% of total revenue) – 4 MAP, Anisole

Other Products (~3% of total revenue)

The company has two manufacturing facilities near Kurkumbh (Maharashtra) and is all set to open the third one very soon. The company has already bought land for setting up a fourth facility, which is expected to be operational by 2023-24. Currently, it has a capacity of 29,900 million tonnes per annum (MTPA), with utilization at 71.94%.

Based on the table above, we get to know that the company is one of the LARGEST manufacturers of the list of speciality chemicals that they manufacture. The company earns most of its revenue from the sale of MEHQ, which is used in manufacturing acrylic fibres, paints and inks, adhesives, and super absorbent polymers.

Close to 69% of the company’s revenue comes from exports, and China is its largest customer. The company exports its products globally to Europe, the USA, China, Korea, Japan.

The top 10 customers contribute nearly 50% to the company’s total revenue. Key customers include Bayer AG, SRF Limited, Gennex Laboratories Limited, Nutriad International NV, and Vinati Organics Limited.

Financial Performance

The company has shown a healthy increase in revenue, profits, and asset value. Apparently, it seems that COVID-19 had a rather small impact on the company’s business, unlike other sectors. Rightly so, because the company manufacturers essential components used in the pharmaceutical industry, which saw a growth opportunity during the pandemic.

Looking at the vital financial ratios of the company, we know that the company saw a healthy rise in EBITDA Margins. It is also using its resources more efficiently as shown by the Return on Capital Employed (ROCE) figures. The company has given a healthy Return on Equity (ROE), which saw a decline during FY21 due to the impact of COVID-19

While comparing its performance with that of peers, we found that the company had the highest EBIDTA margin and Return on Net Worth (RoNW). Even though competitors such as SRF, Navine Flourine, and PI Industries have high revenue figures, they have not able to optimize costs and turn the figures into profit. Meanwhile, Clean Science and Technology has managed to give a bang for the buck (a good value for money), despite having a small market cap compared to its peers. Its business model seems rather sustainable and apt for international expansion.

IPO Details

The company traded at a Grey Market Premium of Rs 450 a day before its listing. Clearly, the company has caught the keen eye of investors, rightly so because of its attractive revenue model. Have you subscribed to the issue? Do you think the company can hit listing gains? Is it the right choice for long-term investment? Let us know in the comment section available on the marketfeed app.